Rockwell Medical Technologies (Nasdaq: RMTI) 20.2% HIGHER; announced that it has signed an exclusive agreement with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (NYSE: BAX), to commercialize Rockwell’s hemodialysis concentrate product line in the U.S. and in select overseas markets.
Durata Therapeutics (Nasdaq: DRTX) 16.2% HIGHER; announced that the Company has received a Special Protocol Agreement (SPA) from the Food and Drug Administration (FDA) on the design of